NEC has developed technologies that enable a secure workflow for personalized cancer vaccines and has proven their capabilities
TOKYO, Apr 1, 2025 – (JCN Newswire via SeaPRwire.com) – NEC Corporation (NEC; TSE: 6701) has developed and successfully demonstrated a technology that enables face recognition without storing patients’ facial information and ensures traceability through the entire workflow process for personalized cancer vaccine. Moreover, NEC has developed and successfully demonstrated a new technology that requires […]